GLP1 NAION warning: FDA orders class-wide labels for potential rare eye risk

Punti riportati da più di una testata

1. FDA requirement for NAION warnings on GLP-1 labels3 testate
2. NAION effects on vision2 testate
3. Drugs covered by the FDA labeling requirement2 testate
4. Evidence included in the FDA evaluation2 testate